Ping Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ping Lu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Caigang Liu
Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China
9 shared publications Feng Jin
The First Affiliated Hospital of China Medial University
6 shared publicationsYang Lu
China Med Univ, Hosp 1, Dept Oncol, Shenyang 110001, Liaoning Prov, Peoples R China
6 shared publicationsHuimian Xu
The First Affiliated Hospital of China Medial University
4 shared publicationsJunqing Chen
China Med Univ, Hosp 1, Dept Oncol, Shenyang 110001, Liaoning Prov, Peoples R China
4 shared publicationsRuishan Zhang
China Med Univ, Hosp 1, Dept Oncol, Shenyang 110001, Liaoning Prov, Peoples R China
3 shared publications
Latest Publications
- Open Access
- 20 June 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 308
Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference
Background: We conducted a retrospective study in our hospital in which we compared D1 with D3 through D2 lymphadenectomy for gastric cancer in terms of morbidity, postoperative mortality, long-term survival after surgery. Methods: 567 patients who were performed curative intent between 1980 and 2003 were enrolled. 187 in the D1 group, 189 in the D2 group and 191 in the D3 group. Every procedure was verified by pathological analyses. The primary endpoints were 5-year overall survival. Results: Median follow-up periods were 36 months and 60 months for D1 group and D3 group. Overall 5-year survival rate was significantly higher in patients underwent D3 surgery than in those performed D1 surgery (37.4% vs 48.7%; log-rank, p = 0.027). For the cases followed up to 120 months, the 10-year overall survival rate was 29% (95% CI, 22.1% to 35.9%) for the D1 group and 33.7% (95% CI, 26.6% to 40.8%) for the D3 group (log-rank, p = 0.005). Conclusions: D1 surgery should be operated only for patients with Borrmann I disease. As D3 gastrectomy is associated with low mortality and adequate survival times when performed in selected institutions that have had sufficient experience with the operation and with postoperative management, we recommend D3 lymphadenectomy for patients with curable gastric cancer.
- 20 June 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 308
Open AccessDoes D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference
Background: We conducted a retrospective study in our hospital in which we compared D1 with D3 through D2 lymphadenectomy for gastric cancer in terms of morbidity, postoperative mortality, long-term survival after surgery. Methods: 567 patients who were performed curative intent between 1980 and 2003 were enrolled. 187 in the D1 group, 189 in the D2 group and 191 in the D3 group. Every procedure was verified by pathological analyses. The primary endpoints were 5-year overall survival. Results: Median follow-up periods were 36 months and 60 months for D1 group and D3 group. Overall 5-year survival rate was significantly higher in patients underwent D3 surgery than in those performed D1 surgery (37.4% vs 48.7%; log-rank, p = 0.027). For the cases followed up to 120 months, the 10-year overall survival rate was 29% (95% CI, 22.1% to 35.9%) for the D1 group and 33.7% (95% CI, 26.6% to 40.8%) for the D3 group (log-rank, p = 0.005). Conclusions: D1 surgery should be operated only for patients with Borrmann I disease. As D3 gastrectomy is associated with low mortality and adequate survival times when performed in selected institutions that have had sufficient experience with the operation and with postoperative management, we recommend D3 lymphadenectomy for patients with curable gastric cancer.
- 1 June 2010
- Published by Springer Nature in The Chinese-German Journal of Clinical Oncology
- Vol. 9 (6) , 321-326
Family history of cancer in Chinese gastric cancer patients
- 1 June 2010
- Published by Springer Nature in The Chinese-German Journal of Clinical Oncology
- Vol. 9 (6) , 321-326
Family history of cancer in Chinese gastric cancer patients
- 31 March 2010
- Published by Elsevier in Surgical Oncology
- Vol. 19 (1) , 4-10
Prognostic role of lymphatic vessel invasion in early gastric cancer: A retrospective study of 188 cases
- 31 March 2010
- Published by Elsevier in Surgical Oncology
- Vol. 19 (1) , 4-10
Prognostic role of lymphatic vessel invasion in early gastric cancer: A retrospective study of 188 cases
- 6 August 2009
- Published by Springer Nature in Medical Oncology
- Vol. 27 (3) , 747-752
Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications
The aim of the study is to investigate the alterations in expression of estrogen receptor alpha (ER), progesterone receptor (PgR), c-erbB2 gene (HER-2/neu), and P53 protein in the progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinomas (IDC), and the association between their expression and clinicopathologic findings. The mastectomy specimens of 520 cases containing both DCIS and IDC were examined. The expression of ER, PgR, HER-2/neu, and P53 proteins were examined by immunohistochemistry. Linear regression was used to investigate the correlation among ER, PgR, HER-2/neu, P53 protein expression, and the clinicopathologic factors. There was a significant decrease of ER and PgR expression in IDC compared to DCIS (32.81 vs. 21.05%, χ2 = 4.45, P = 0.035; 26.56 vs. 15.57%, χ2 = 4.82, P = 0.028, respectively). In contrast, there was a significant increase of HER-2/neu expression in IDC compared to DCIS (10.94 vs. 21.27%, χ2 = 3.88, P = 0.049). However, there was no significant difference in expression of p53 between DCIS and IDC. In both DCIS and IDC, a significant positive correlation was observed between ER and PgR receptor expression (r = 0.67, P = 0.00; r = 0.56, P = 0.00, respectively). In conclusion, these findings substantiate the notion that breast cancer progression is often associated with alterations in expressions of ER, PgR, and HER-2/neu. The underlying mechanisms of these alterations need further investigation.
- 6 August 2009
- Published by Springer Nature in Medical Oncology
- Vol. 27 (3) , 747-752
Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications
The aim of the study is to investigate the alterations in expression of estrogen receptor alpha (ER), progesterone receptor (PgR), c-erbB2 gene (HER-2/neu), and P53 protein in the progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinomas (IDC), and the association between their expression and clinicopathologic findings. The mastectomy specimens of 520 cases containing both DCIS and IDC were examined. The expression of ER, PgR, HER-2/neu, and P53 proteins were examined by immunohistochemistry. Linear regression was used to investigate the correlation among ER, PgR, HER-2/neu, P53 protein expression, and the clinicopathologic factors. There was a significant decrease of ER and PgR expression in IDC compared to DCIS (32.81 vs. 21.05%, χ2 = 4.45, P = 0.035; 26.56 vs. 15.57%, χ2 = 4.82, P = 0.028, respectively). In contrast, there was a significant increase of HER-2/neu expression in IDC compared to DCIS (10.94 vs. 21.27%, χ2 = 3.88, P = 0.049). However, there was no significant difference in expression of p53 between DCIS and IDC. In both DCIS and IDC, a significant positive correlation was observed between ER and PgR receptor expression (r = 0.67, P = 0.00; r = 0.56, P = 0.00, respectively). In conclusion, these findings substantiate the notion that breast cancer progression is often associated with alterations in expressions of ER, PgR, and HER-2/neu. The underlying mechanisms of these alterations need further investigation.
- 31 December 2008
- Published by Elsevier in Surgical Oncology
- Vol. 17 (4) , 317-322
Prognostic significance of subclassification of pT2 gastric cancer: A retrospective study of 847 patients
- 31 December 2008
- Published by Elsevier in Surgical Oncology
- Vol. 17 (4) , 317-322
Prognostic significance of subclassification of pT2 gastric cancer: A retrospective study of 847 patients
- 1 June 2008
- Published by Springer Nature in The Chinese-German Journal of Clinical Oncology
- Vol. 7 (6) , 358-360
Protection of a cytidine deaminase gene gainst toxicity of high dose chemotherapy in mice
- 1 June 2008
- Published by Springer Nature in The Chinese-German Journal of Clinical Oncology
- Vol. 7 (6) , 358-360
Protection of a cytidine deaminase gene gainst toxicity of high dose chemotherapy in mice
- Open Access
- 24 October 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 200
Clinical implications of metastatic lymph node ratio in gastric cancer
The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node metastasis in gastric cancer in Chinese.
- 24 October 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 200
Open AccessClinical implications of metastatic lymph node ratio in gastric cancer
The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node metastasis in gastric cancer in Chinese.
- 1 April 2007
- Published by Springer Nature in Chinese Journal of Clinical Oncology
- Vol. 4 (2) , 89-92
Rational operation for primary gastric carcinoma with liver metastasis
- 1 April 2007
- Published by Springer Nature in Chinese Journal of Clinical Oncology
- Vol. 4 (2) , 89-92
Rational operation for primary gastric carcinoma with liver metastasis
- Open Access
- 1 January 2007
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (35) , 4776-80
Distribution of solitary lymph nodes in primary gastric cancer: A retrospective study and clinical implications
To investigate the distribution pathway of metastatic lymph nodes in gastric carcinoma as a foundation for rational lymphadenectomy. We investigated 173 cases with solitary or single station metastatic lymph nodes (LN) from among 2476 gastric carcinoma patients. The location of metastatic LN, histological type and growth patterns were analyzed retrospectively. Of 88 solitary node metastases cases, 65 were limited to perigastric nodes (N(1)), while 23 showed skipping metastasis. Among 8 tumors in the upper third stomach, 3 involved right paracardial LN (station number: No.1), and one in the greater curvature was found in No.1. In the 28 middle third stomach tumors, 10 were found in LN of the lesser curvature (No.3) and 6 in LN of the left gastric artery (No.7); 5 of the 20 cases on the lesser curvature spread to No.7, while 2 of the 8 on the greater curvature metastasized to LN of the spleen hilum (No.10). Of 52 lower third stomach tumors, 13 involved in No.3 and 19 were detected in inferior pyloric LN (No.6); 9 of the 29 cases along the lesser curvature were involved in No.6. Transversal and skipping metastases of sentinel lymph nodes (SLN) are notable, and rational lymphadenectomy should, therefore, be performed.
- 1 January 2007
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (35) , 4776-80
Open AccessDistribution of solitary lymph nodes in primary gastric cancer: A retrospective study and clinical implications
To investigate the distribution pathway of metastatic lymph nodes in gastric carcinoma as a foundation for rational lymphadenectomy. We investigated 173 cases with solitary or single station metastatic lymph nodes (LN) from among 2476 gastric carcinoma patients. The location of metastatic LN, histological type and growth patterns were analyzed retrospectively. Of 88 solitary node metastases cases, 65 were limited to perigastric nodes (N(1)), while 23 showed skipping metastasis. Among 8 tumors in the upper third stomach, 3 involved right paracardial LN (station number: No.1), and one in the greater curvature was found in No.1. In the 28 middle third stomach tumors, 10 were found in LN of the lesser curvature (No.3) and 6 in LN of the left gastric artery (No.7); 5 of the 20 cases on the lesser curvature spread to No.7, while 2 of the 8 on the greater curvature metastasized to LN of the spleen hilum (No.10). Of 52 lower third stomach tumors, 13 involved in No.3 and 19 were detected in inferior pyloric LN (No.6); 9 of the 29 cases along the lesser curvature were involved in No.6. Transversal and skipping metastases of sentinel lymph nodes (SLN) are notable, and rational lymphadenectomy should, therefore, be performed.